Diabetes exacerbates nanoparticles induced brain pathology

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 1, 2012, Pages 26-39

  Lafuente, José Vicente ^a   Sharma, Aruna ^b   Patnaik, Ranjana ^c   Muresanu, Dafin Fior ^d   Sharma, Hari Shanker ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c BANARAS HINDU UNIVERSITY   (India)

^d IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Ag; Blood brain barrier; Brain edema; Cerebral blood flow; Cognitive disturbances; Cu; Diabetes; Electron microscopy; Hyperglycemia; Myelin damage; Nanoparticles; Neuronal injury; Neurotoxicity; Sensory motor function; SiO2; Streptozotocine

Indexed keywords

CHLORIDE ION; COPPER; ELECTROLYTE; GLUCOSE; INSULIN; NANOPARTICLE; POTASSIUM ION; SILICON DIOXIDE; SILVER NANOPARTICLE; SODIUM CHLORIDE; SODIUM ION;

ARGYRIA; BLOOD BRAIN BARRIER; BODY FLUID; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN DISEASE; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN STEM; BRAIN WATER; CAUDATE NUCLEUS; CELL DAMAGE; CEREBELLUM CORTEX; CEREBELLUM VERMIS; CEREBROVASCULAR DISEASE; CINGULATE GYRUS; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE EXACERBATION; ELECTRON MICROSCOPY; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; HEAT STRESS; HEAVY METAL POISONING; HIPPOCAMPUS; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS; MEDULLA OBLONGATA; METABOLIC DISORDER; NEUROTOXICITY; NONHUMAN; OCCIPITAL CORTEX; OXIDATIVE STRESS; PARIETAL CORTEX; PONS; REVIEW; SENSORIMOTOR FUNCTION; SPINAL CORD; SPINAL CORD INJURY; STREPTOZOCIN DIABETES; THALAMUS; WATER CONTENT;

EID: 84860340317     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712799960808     Document Type: Review

References (93)

1. Sharma, H.S.; Sharma, A. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2012, 4(2): 184-203.
2. Lucchini, R.G.; Dorman, D.C.; Elder, A.; Veronesi, B. Neurological impacts from inhalation of pollutants and the nosebrain connection. Neurotoxicology, 2011, [Epub ahead of print].
3. Song, Y.; Tang, S. Nanoexposure, unusual diseases, and new health and safety concerns. Sci. World J., 2011, 11, 1821-1828.
4. Zhang, R.; Bai, Y.; Zhang, B.; Chen, L.; Yan, B. The potential health risk of titania nanoparticles. J. Hazard. Mater., 2011, [Epub ahead of print].
5. Beurskens-Comuth, P.A.; Verbist, K.; Brouwer, D. Video exposure monitoring as part of a strategy to assess exposure to nanoparticles. Ann. Occup. Hyg., 2011, 55(8), 937-945.
6. Jachak, A.; Lai, S.K.; Hida, K.; Suk, J.S.; Markovic, N.; Biswal, S.; Breysse, P.N.; Hanes, J. Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology, 2011 [Epub ahead of print].
7. Leppänen, M.; Lyyränen, J.; Järvelä, M.; Auvinen, A.; Jokiniemi, J.; Pimenoff, J.; Tuomi, T. Exposure to CeO(2) nanoparticles during flame spray process. Nanotoxicology, 2011, [Epub ahead of print].
8. Könczöl, M.; Ebeling, S.; Goldenberg, E.; Treude, F.; Gminski, R.; Gieré, R.; Grobéty, B.; Rothen-Rutishauser, B.; Merfort, I.; Mersch-Sundermann, V. Cytotoxicity and genotoxicity of sizefractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem. Res. Toxicol., 2011, 24(9), 1460-1475.
9. Sharma, H.S.; Muresanu, D.F.; Patnaik, R.; Stan, A.D.; Vacaras, V.; Perju-Dumbrav, L.; Alexandru, B.; Buzoianu, A.; Opincariu, I.; Menon, P.K.; Sharma, A. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. J. Nanosci. Nanotechnol., 2011, 11(9), 7549-769.
10. Sharma, H.S.; Patnaik, R.; Sharma, A. Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol., 2010, 10(12), 7931-7945.
11. Sun, J.; Wang, S.; Zhao, D.; Hun, F.H.; Weng, L.; Liu, H. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol. Toxicol., 2011, 27(5), 333-342.
12. Peters, A.; Rückerl, R.; Cyrys, J. Lessons from air pollution epidemiology for studies of engineered nanomaterials. J. Occup. Environ. Med., 2011, 53(6 Suppl), S8-S13.
13. Li, N.; Nel, A.E. Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research. J. Occup. Environ. Med., 2011, 53(6 Suppl), S74-S79.
14. Schubauer-Berigan, M.K.; Dahm, M.M.; Yencken, M.S. Engineered carbonaceous nanomaterials manufacturers in the United States: workforce size, characteristics, and feasibility of epidemiologic studies. J. Occup. Environ Med., 2011, 53(6 Suppl), S62-S67.
15. Eisen, E.A.; Costello, S.; Chevrier, J.; Picciotto, S. Epidemiologic challenges for studies of occupational exposure to engineered nanoparticles; a commentary. J. Occup. Environ. Med., 2011, 53(6 Suppl), S57-S61.
16. Zhang, L.; Bai, R.; Liu, Y.; Meng, L.; Li, B.; Wang, L.; Xu, L.; Le Guyader, L.; Chen, C. The dose-dependent toxicological effects and potential perturbation on the neurotransmitter secretion in brain following intranasal instillation of copper nanoparticles. Nanotoxicology, 2011, [Epub ahead of print].
17. Heng, B.C.; Zhao, X.; Tan, E.C.; Khamis, N.; Assodani, A.; Xiong, S.; Ruedl, C.; Ng, K.; Loo, J.S. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch. Toxicol., 2011, 85(12), 1517-1528.
18. Chow, J.C.; Watson, J.G.; Savage, N.; Solomon, C.J.; Cheng, Y.S.; McMurry, P.H.; Corey, L.M.; Bruce, G.M.; Pleus, R.C.; Biswas, P.; Wu, C.Y. Nanoparticles and the environment. J. Air Waste Manag. Assoc., 2005, 55(10), 1411-1417.
19. Sharma, H.S. Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection. J. Neural Transm., 2011, 118(1), 155-176.
20. Sharma, H.S.; Sharma, A.; Hussain, S.; Schlager, J.; Sjöquist, P.O.; Muresanu, D. A new antioxidant compound H-290/51 attenuates nanoparticle induced neurotoxicity and enhances neurorepair in hyperthermia. Acta Neurochir. Suppl., 2010, 106, 351-357.
21. Sharma, H.S.; Sharma, A. Breakdown Of The Blood-Brain Barrier In Stress Alters Cognitive Dysfunction And Induces Brain Pathology. New Perspective For Neuroprotective Strategies. In: Ritsner, M., Ed.; Brain Protection in Schizophrenia, Mood and Cognitive Disorders, 2010. Springer-Verlag, Berlin, New York, 2010, pp. 243-304.
22. Sharma, H.S. Blood-Central Nervous System Barriers: The Gateway to Neurodegeneration, Neuroprotection and Neuroregeneration. In: Lajtha, A., Banik, N., Ray, S.K., Eds.; Handbook of Neurochemistry and Molecular Neurobiology: Brain and Spinal Cord Trauma. Springer Verlag, Berlin, Heidelberg, New York, 2009, pp. 363-457.
23. Sharma, H.S.; Sharma, A. Nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives. Nanomedicine (Lond.), 2010, 5(4), 533-537.
24. Muresanu, D.F.; Sharma, H.S. Chronic hypertension aggravates heat stress induced cognitive dysfunction and brain pathology: an experimental study in the rat, using growth hormone therapy for possible neuroprotection. Ann. NY Acad. Sci., 2007, 1122, 1-22.
25. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Hussain, S.M.; Schlager, J.J.; Sjöquist, P.O.; Sharma, A.; Muresanu, D.F. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H- 290/51. J. Nanosci. Nanotechnol., 2009, 9(8), 5073-5090.
26. Sharma, H.S.; Ali, S.F.; Hussain, S.M.; Schlager, J.J.; Sharma A. Influence of engineered nanoparticles from metals on the bloodbrain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 5055-5072.
27. Sharma, H.S.; Sharma, A. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part I. Expert Rev. Neurother., 2010, 10(7), 1039-1043.
28. Muresanu, D.F.; Sharma, A.; Sharma, H.S. Diabetes aggravates heat stress-induced blood-brain barrier breakdown, reduction in cerebral blood flow, edema formation, and brain pathology: possible neuroprotection with growth hormone. Ann. NY Acad. Sci., 2010, 1199, 15-26.
29. Muresanu, D.F.; Zimmermann-Meinzingen, S.; Sharma, H.S. Chronic hypertension aggravates heat stress-induced brain damage: possible neuroprotection by cerebrolysin. Acta Neurochir. Suppl., 2010, 106, 327-333.
30. Sharma, H.S.; Hussain, S.; Schlager, J.; Ali, S.F.; Sharma, A. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir. Suppl., 2010, 106, 359-364.
31. Sharma, H.S. A special section on nanoneuroscience: nanoneurotoxicity and nanoneuroprotection. J. Nanosci. Nanotechnol., 2009, 9(8), 4992-4995.
32. Sharma, H.S. Nanoneuroscience and Nanoneuropharmacology. Prog. Brain Res., 2009, 180, 1-286.
33. Sharma, H.S.; Sharma, A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res., 2007, 162, 245-273.
34. Sharma, H.S.; Sharma, A.; Hussain, S.; Schlager, J.; Sjöquist, P.O.; Muresanu, D. A new antioxidant compound H-290/51 attenuates nanoparticle induced neurotoxicity and enhances neurorepair in hyperthermia. Acta Neurochir. Suppl., 2010, 106, 351-357.
35. Stone, V.; Donaldson, K. Nanotoxicology: signs of stress. Nat. Nanotechnol., 2006, 1(1), 23-24.
36. Rahman, M.F.; Wang, J.; Patterson, T.A.; Saini, U.T.; Robinson, B.L.; Newport, G.D.; Murdock, R.C.; Schlager, J.J.; Hussain, S.M.; Ali, S.F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett., 2009, 187(1), 15-21.
37. Oberdörster, G.; Elder, A.; Rinderknecht, A. Nanoparticles and the brain: cause for concern? J. Nanosci. Nanotechnol., 2009, 9(8), 4996-5007.
38. Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med., 2010, 267(1), 89-105.
39. Win-Shwe, T.T.; Mitsushima, D.; Yamamoto, S.; Fujitani, Y.; Funabashi, T.; Hirano, S.; Fujimaki, H. Extracellular glutamate level and NMDA receptor subunit expression in mouse olfactory bulb following nanoparticle-rich diesel exhaust exposure. Inhal. Toxicol., 2009, 21(10), 828-836.
40. van Berlo, D.; Albrecht, C.; Knaapen, A.M.; Cassee, F.R.; Gerlofs-Nijland, M.E.; Kooter, I.M.; Palomero-Gallagher, N.; Bidmon, H.J.; van Schooten, F.J.; Krutmann, J.; Schins, R.P. Comparative evaluation of the effects of short-term inhalation exposure to diesel engine exhaust on rat lung and brain. Arch. Toxicol., 2010, 84(7), 553-562.
41. Long, T.C.; Saleh, N.; Tilton, R.D.; Lowry, G.V.; Veronesi, B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol., 2006, 40(14), 4346-4352.
42. Sharma, H.S. Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomedicine (Lond.), 2007, 2(6), 753-758.
43. Glaser, N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr. Diabetes, 2009, 10(8), 534-541.
44. Hoffman, W.H.; Stamatovic, S.M.; Andjelkovic, A.V. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res., 2009, 1254, 138-148.
45. Yuen, N.; Anderson, S.E.; Glaser, N.; Tancredi, D.J.; O'Donnell, M.E. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes, 2008, 57(10), 2588-2594.
46. Sonaje, K.; Chen, Y.J.; Chen, H.L.; Wey, S.P.; Juang, J.H.; Nguyen, H.N.; Hsu, C.W.; Lin, K.J.; Sung, H.W. Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials, 2010, 31(12), 3384-3394.
47. Sun, S.; Liang, N.; Piao, H.; Yamamoto, H.; Kawashima, Y.; Cui, F. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation. J. Microencapsul., 2010, 27(6), 471-478.
48. Bi, R.; Shao, W.; Wang, Q.; Zhang, N. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. J. Biomed. Nanotechnol., 2009, 5(1), 84-92.
49. Chen, X.; Schluesener, H.J. Nanosilver: a nanoproduct in medical application. Toxicol. Lett., 2008, 176(1), 1-12.
50. Kim, J.H.; Kim, K.W.; Kim, M.H.; Yu, Y.S. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology, 2009, 20(50), 505101.
51. Ting, J.H.; Martin, D.K. Basic and clinical aspects of gene therapy for retinopathy induced by diabetes. Curr. Gene Ther., 2006, 6(2), 193-214.
52. Sheikpranbabu, S.; Kalishwaralal, K.; Lee, K.J.; Vaidyanathan, R.; Eom, S.H.; Gurunathan, S. The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles. Biomaterials, 2010, 31(8), 2260-2271.
53. Powers, C.M.; Wrench, N.; Ryde, I.T.; Smith, A.M.; Seidler, F.J.; Slotkin, T.A. Silver impairs neurodevelopment: studies in PC12 cells. Environ. Health Perspect., 2010, 118(1), 73-79.
54. Sharma, H.S.; Dey, P.K. EEG changes following increased bloodbrain barrier permeability under long-term immobilization stress in young rats. Neurosci. Res., 1988, 5(3), 224-239.
55. Sharma, H.S.; Dey, P.K. Influence of long-term acute heat exposure on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Brain Res., 1987, 424(1), 153-162.
56. Sharma, H.S.; Dey, P.K. Probable involvement of 5- hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology, 1986, 25(2), 161-167.
57. Sharma, H.S.; Olsson, Y.; Dey, P.K. Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats. Brain Res., 1990, 517(1-2), 215-223.
58. Sharma, H.S. Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology, 1987, 26(1), 85-92.
59. Sharma, H.S.; Cervós-Navarro, J.; Dey, P.K. Acute heat exposure causes cellular alteration in cerebral cortex of young rats. Neuroreport, 1991, 2(3), 155-158.
60. Sharma, H.S.; Cervós-Navarro, J. Brain oedema and cellular changes induced by acute heat stress in young rats. Acta Neurochir. Suppl. (Wien.), 1990, 51, 383-386.
61. Sharma, H.S.; Nyberg, F.; Cervos-Navarro, J.; Dey, P.K. Histamine modulates heat stress-induced changes in blood-brain barrier permeability, cerebral blood flow, brain oedema and serotonin levels: an experimental study in conscious young rats. Neuroscience, 1992, 50(2), 445-454.
62. Kiyatkin, E.A.; Sharma, H.S. Permeability of the blood-brain barrier depends on brain temperature. Neuroscience, 2009, 161(3), 926-939.
63. Sharma, H.S.; Kiyatkin, E.A. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat., 2009, 37(1), 18-32.
64. Kiyatkin, E.A.; Brown, P.L.; Sharma, H.S. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur. J. Neurosci., 2007, 26(5), 1242-1253.
65. Sharma, H.S.; Westman, J.; Cervós-Navarro, J.; Dey, P.K.; Nyberg, F. Opioid receptor antagonists attenuate heat stress-induced reduction in cerebral blood flow, increased blood-brain barrier permeability, vasogenic edema and cell changes in the rat. Ann. NY Acad. Sci., 1997, 813, 559-571.
66. Sharma, H.S.; Olsson, Y. Edema formation and cellular alterations following spinal cord injury in the rat and their modification with p-chlorophenylalanine. Acta Neuropathol., 1990, 79(6), 604-610.
67. Olsson, Y.; Sharma, H.S.; Pettersson, C.A. Effects of pchlorophenylalanine on microvascular permeability changes in spinal cord trauma. An experimental study in the rat using 131Isodium and lanthanum tracers. Acta Neuropathol., 1990, 79(6), 595-603.
68. Pettersson, C.A.; Sharma, H.S.; Olsson, Y. Vascular permeability of spinal nerve roots. A study in the rat with Evans blue and lanthanum as tracers. Acta Neuropathol., 1990, 81(2), 148-154.
69. Berger, M. Military Nanotechnology - How Worried Should We Be? Nanowerk LLC. 2006, http,//www.nanowerk.com/spotlight/spotid=1015.php [accessed on Feb 05, 2011].
70. Sharma, H.S.; Muresanu, D.F.; Sharma, A.; Patnaik, R.; Lafuente, J.V. Chapter 9 - Nanoparticles influence pathophysiology of spinal cord injury and repair. Prog. Brain Res., 2009, 180, 154-180.
71. Sharma, H.S.; Patnaik, R.; Sharma, A.; Sjöquist, P.O.; Lafuente, J.V. Silicon dioxide nanoparticles (SiO2, 40-50 nm) exacerbate pathophysiology of traumatic spinal cord injury and deteriorate functional outcome in the rat. An experimental study using pharmacological and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 4970-4980.
72. Rushton, E.K.; Jiang, J.; Leonard, S.S.; Eberly, S.; Castranova, V.; Biswas, P.; Elder, A.; Han, X.; Gelein, R.; Finkelstein, J.; Oberdörster, G. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J. Toxicol. Environ. Health A, 2010, 73(5), 445-461.
73. Kreyling, W.G.; Semmler-Behnke, M.; Seitz, J.; Scymczak, W.; Wenk, A.; Mayer, P.; Takenaka, S.; Oberdörster, G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol., 2009, 21(Suppl 1), 55-60.
74. Vanwinkle, B.A.; de Mesy Bentley, K.L.; Malecki, J.M.; Gunter, K.K.; Evans, I.M.; Elder, A.; Finkelstein, J.N.; Oberdörster, G.; Gunter, T.E. Nanoparticle (NP) uptake by type I alveolar epithelial cells and their oxidant stress response. Nanotoxicology, 2009, 3(4), 307-318.
75. Hirano, S. A current overview of health effect research on nanoparticles. Environ. Health Prev. Med., 2009, 14(4), 223-225.
76. Hillman, K.L.; Bilkey, D.K. Neurons in the rat anterior cingulate cortex dynamically encode cost-benefit in a spatial decisionmaking task. J. Neurosci., 2010, 30(22), 7705-7713.
77. Jankord, R.; Zhang, R.; Flak, J.N.; Solomon, M.B.; Albertz, J.; Herman, J.P. Stress activation of IL-6 neurons in the hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2010, 299(1), R343-R351.
78. Sharma, H.S.; Westman, J.; Nyberg, F. Pathophysiology of brain edema and cell changes following hyperthermic brain injury. Prog. Brain Res., 1998, 115, 351-412.
79. Sharma, H.S.; Muresanu, D.; Sharma, A.; Patnaik, R. Cocaineinduced breakdown of the blood-brain barrier and neurotoxicity. Int. Rev. Neurobiol., 2009, 88, 297-334.
80. Kiyatkin, E.A.; Sharma, H.S. Acute methamphetamine intoxication brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int. Rev. Neurobiol., 2009, 88, 65-100.
81. Sharma, H.S.; Ali, S.F. Acute administration of 3,4- methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. Ann. NY Acad. Sci., 2008, 1139, 242-258.
82. Sharma, H.S.; Sjöquist, P.O. A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in the rat spinal cord following trauma. Amino Acids, 2002, 23(1-3), 261-272.
83. Li, P.A.; Gisselsson, L.; Keuker, J.; Vogel, J.; Smith, M.L.; Kuschinsky, W.; Siesjö, B.K. Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction. Brain Res., 1998, 804(1), 36-44.
84. Ding, C.; He, Q.; Li, P.A. Diabetes increases expression of ICAM after a brief period of cerebral ischemia. J. Neuroimmunol., 2005, 161(1-2), 61-67.
85. Drews, G.; Krippeit-Drews, P.; Düfer, M. Oxidative stress and beta-cell dysfunction. Pflugers Arch., 2010, [Epub ahead of print].
86. Sharma, H.S.; Sjöquist, P.O.; Ali, S.F. Alterations in blood-brain barrier function and brain pathology by morphine in the rat. Neuroprotective effects of antioxidant H-290/51. Acta Neurochir. Suppl., 2010, 106, 61-66.
87. Fenoglio, I.; Tomatis, M.; Lison, D.; Muller, J.; Fonseca, A.; Nagy, J.B.; Fubini, B. Reactivity of carbon nanotubes, free radical generation or scavenging activity? Free Radic. Biol. Med., 2006, 40(7), 1227-1233.
88. Shvedova, A.A.; Kisin, E.R.; Murray, A.; Kommineni, C.; Vallyathan, V.; Castranova, V. Pro/antioxidant status in murine skin following topical exposure to cumene hydroperoxide throughout the ontogeny of skin cancer. Biochemistry (Mosc.), 2004, 69(1), 23-31.
89. Manna, S.K.; Sarkar, S.; Barr, J.; Wise, K.; Barrera, E.V.; Jejelowo, O.; Rice-Ficht, A.C.; Ramesh, G.T. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. NanoLetters, 2005, 5(9), 1676-1684.
90. Sharma, H.S.; Ali, S.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Lek, P.; Sharma, A.; Lundstedt, T. Nano-drug delivery and neuroprotection in spinal cord injury. J. Nanosci. Nanotechnol., 2009, 9(8), 5014-5037.
91. Sharma, H.S.; Ali, S.F.; Dong, W.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Sharma, A.; Boman, A.; Lek, P.; Seifert, E.; Lundstedt, T. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord. Ann. NY Acad. Sci., 2007, 1122, 197-218.
92. Sharma, H.S.; Sjöquist, P.O.; Ali, S.F. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity, neuroprotective effects of a new antioxidant compound H-290/51. Curr. Pharm. Des., 2007, 13(18), 1903-1923.
93. Sharma, H.S.; Gordh, T.; Wiklund, L.; Mohanty, S.; Sjöquist, P.O. Spinal cord injury induced heat shock protein expression is reduced by an antioxidant compound H-290/51. An experimental study using light and electron microscopy in the rat. J. Neural Transm., 2006, 113(4), 521-536.